AngioDynamics (ANGO) Misses Q2 EPS by 2c; Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of ($0.02), $0.02 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $78.3 million versus the consensus estimate of $77.88 million.

GUIDANCE:

AngioDynamics sees FY2022 EPS of ($0.02)-$0.02, versus the consensus of $0.02. AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $313.7 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance